D. Roth

发表

Randomized Trial of Mycophenolate Mofetil Versus Enteric-Coated Mycophenolate Sodium in Primary Renal Transplant Recipients Given Tacrolimus and Daclizumab/Thymoglobulin: One Year Follow-Up

J. Gaynor, G. Ciancio, G. Burke, 2008, Transplantation.

Predisposing Factors of Diminished Survival in Simultaneous Liver/Kidney Transplantation

T. Hibi, G. Selvaggi, S. Nishida, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: evidence of endothelin and cytokine involvement.

A. Tzakis, G. Ciancio, G. Burke, 1999, Transplantation.

A. Tzakis, G. Ciancio, G. Burke, 1998, Transplantation proceedings.

Kidney allograft survival of African American and Caucasian American recipients with lupus

H. Li, G. Ciancio, D. Roth, 2014, Lupus.

Favorable Outcomes With Machine Perfusion and Longer Pump Times in Kidney Transplantation: A Single-Center, Observational Study

W. O’Neill, J. Gaynor, G. Ciancio, 2010, Transplantation.

Medical management of the kidney transplant recipient: a practical approach for the primary care provider.

D. Roth, F. Pedraza, 2014, Primary care.

A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. Ii. Survival, function, and protocol compliance at 1 year

J. Gaynor, G. Ciancio, G. Burke, 2004, Transplantation.

A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year

J. Gaynor, G. Ciancio, G. Burke, 2004, Transplantation.

Hepatitis C Virus Infection in Chronic Kidney Disease.

D. Roth, F. Pedraza, M. Ladino, 2016, Journal of the American Society of Nephrology : JASN.

J. Gaynor, G. Ciancio, G. Burke, 2018 .

Cost‐effectiveness of elbasvir/grazoprevir use in treatment‐naive and treatment‐experienced patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States

E. Elbasha, D. Roth, W. Greaves, 2017, Journal of viral hepatitis.

Evaluation of fluvastatin in the treatment of hypercholesterolemia in renal transplant recipients taking cyclosporine.

R. Goldberg, D. Roth, Ronald N. Goldberg, 1996, Transplantation.

Sequential therapies for proliferative lupus nephritis.

D. Roth, V. Pardo, O. Lenz, 2004, The New England journal of medicine.

Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study

T. Hassanein, S. Pol, D. Nelson, 2015, The Lancet.

Recurrence of lupus nephritis after kidney transplantation.

L. Tamariz, D. Roth, W. Kupin, 2010, Journal of the American Society of Nephrology : JASN.

Comparison of mortality of ESRD patients with lupus by initial dialysis modality.

P. Byers, D. Roth, O. Lenz, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Project HELP: a study protocol to pilot test a shared decision-making tool about treatment options for patients with hepatitis C and chronic kidney disease

David Roth, J. Yee, M. Politi, 2018, Pilot and Feasibility Studies.

Management of hepatitis C infection in kidney transplant candidates

D. Roth, S. Virmani, 2014 .

What are the Management Issues for Hepatitis C in Dialysis Patients?

D. Roth, S. Virmani, 2014, Seminars in dialysis.

Direct‐Acting Antiviral Agents for the Hepatitis C Virus‐Infected Chronic Kidney Disease Population: The Dawn of a New Era

D. Roth, J. Kusnir, 2016, Seminars in dialysis.

The evaluation of renal transplantation candidates: clinical practice guidelines.

B. Kasiske, D. Rush, C. Cangro, 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Hepatitis in the Renal Patient

D. Roth, G. Perez, 1998 .

Hepatitis C virus: the nephrologist's view.

D. Roth, David Roth, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The impact of hepatitis C virus infection on renal allograft recipients.

G. Burke, D. Roth, Joshua Miller, 1994, Kidney international.

Antibody‐mediated rejection implies a poor prognosis in kidney transplantation: Results from a single center

J. Gaynor, G. Ciancio, G. Burke, 2018, Clinical transplantation.

Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease

D. Roth, F. Pedraza, M. Ladino, 2017, World journal of hepatology.

A Randomized Pilot Study of Donor Stem Cell Infusion in Living-Related Kidney Transplant Recipients Receiving Alemtuzumab

C. Ricordi, J. Gaynor, G. Ciancio, 2013, Transplantation.

SIX-YEAR CLINICAL EFFECT OF DONOR BONE MARROW INFUSIONS IN RENAL TRANSPLANT PATIENTS1

C. Ricordi, A. Tzakis, G. Ciancio, 2001, Transplantation.

Donor bone marrow infusion in renal transplantation.

C. Ricordi, A. Tzakis, G. Ciancio, 1998, Transplantation Proceedings.

Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.

C. Ricordi, N. Kenyon, A. Tzakis, 1998, Transplantation.

The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.

C. Ricordi, A. Tzakis, G. Ciancio, 1997, The Journal of clinical investigation.

PCR-flow analysis used to detect the levels of chimerism in peripheral blood of bone-marrow infused organ allograft recipients at the time of rejection episodes.

C. Ricordi, A. Tzakis, G. Ciancio, 1997, Transplantation proceedings.

Tacrolimus and Mycophenolate Mofetil Regimens in Transplantation

G. Ciancio, G. Burke, D. Roth, 1999, BioDrugs.

Management of the waiting list for cadaveric kidney transplants: report of a survey and recommendations by the Clinical Practice Guidelines Committee of the American Society of Transplantation.

D. Rush, G. Danovitch, R. Starling, 2002, Journal of the American Society of Nephrology : JASN.

Renal transplantation in systemic lupus erythematosus: one center's experience.

D. Roth, V. Esquenazi, G. Zilleruelo, 1987, American journal of nephrology.

Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients1

G. Ciancio, G. Burke, D. Roth, 2002, Transplantation.

Transplant-associated autoimmune mechanisms in human hepatitis C virus infection

A. Tzakis, G. Burke, D. Roth, 2005, Journal of Clinical Immunology.

Transmission of hepatitis C virus by kidney transplantation: impact of perfusion techniques and course of viremia post transplant

G. Burke, D. Roth, Joshua Miller, 2004, Pediatric Nephrology.

Renal Disease in Patients Infected with Hepatitis and Human Immunodeficiency Virus

D. Roth, J. Bourgoignie, T. Rao, 2000 .

Differential effects of IFN-gamma on kidney cell expression of MHC class II molecules, kidney cell associated molecules and their stimulatory capacity in mixed lymphocyte kidney cell culture.

P. Lu, G. Burke, D. Roth, 1993, Transplant immunology.

Characterization of anti-canine cytokine monoclonal antibodies specific for IFN-γ: Effect of anti-IFN-γ on renal transplant rejection

G. Burke, D. Roth, Joshua Miller, 1994 .

Cholesterol control: long-term benefit of pancreas-kidney transplantation with FK 506 immunosuppression.

J. Skyler, C. Ricordi, R. Alejandro, 1998, Transplantation proceedings.

A Randomized Trial of Three Renal Transplant Induction Antibodies: Early Comparison of Tacrolimus, Mycophenolate Mofetil, and Steroid Dosing, and Newer Immune-Monitoring1

J. Gaynor, A. Tzakis, G. Ciancio, 2005, Transplantation.

A Randomized Long-Term Trial of Tacrolimus/Sirolimus versus Tacrolimums/Mycophenolate versus Cyclosporine/Sirolimus in Renal Transplantation: Three-Year Analysis

J. Gaynor, G. Ciancio, G. Burke, 2006, Transplantation.

Advantage of Rapamycin Over Mycophenolate Mofetil When Used With Tacrolimus for Simultaneous Pancreas Kidney Transplants: Randomized, Single‐Center Trial at 10 Years

A. Fornoni, J. Gaynor, G. Ciancio, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Prolonged lymphocyte depletion by single-dose rabbit anti-thymocyte globulin and alemtuzumab in kidney transplantation.

J. Gaynor, G. Ciancio, G. Burke, 2011, Transplant immunology.

Early development of acute myelogenous leukemia following kidney transplantation: possible role of multiple serum cytokines.

G. Burke, D. Roth, Joshua Miller, 1995, Leukemia & lymphoma.

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

E. Salido, M. Sarwal, M. Rastaldi, 2011, Nature Medicine.

Post-transplant lymphoproliferative disease in kidney transplant patients in the new immunosuppressive era.

G. Ciancio, G. Burke, D. Roth, 1997, Clinical transplantation.

Results of renal transplantation in Miami analyzed by race.

G. Burke, D. Roth, V. Esquenazi, 1989, Transplantation proceedings.

Predictors of reduced tacrolimus dose and trough level through 36 months post‐transplant among 578 adult primary kidney transplant recipients

J. Gaynor, G. Ciancio, G. Burke, 2014 .

A Patient Decision Support Tool for Hepatitis C Virus and CKD Treatment

J. Yee, Tingting Li, M. Politi, 2019, Kidney medicine.

Machine perfusion following static cold storage preservation in kidney transplantation: donor‐matched pair analysis of the prognostic impact of longer pump time

J. Gaynor, G. Ciancio, G. Burke, 2012, Transplant international : official journal of the European Society for Organ Transplantation.

Excessive immunosuppression as a potential cause of poor survival in simultaneous liver/kidney transplantation for hepatitis C

T. Hibi, S. Nishida, D. Levi, 2014, Transplant international : official journal of the European Society for Organ Transplantation.

Peritoneal Dialysis Underutilization: The Impact of an Interventional Nephrology Peritoneal Dialysis Access Program

P. Byers, D. Roth, A. Asif, 2003, Seminars in dialysis.

KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C.

N. Terrault, P. Reese, M. Molnar, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Elbasvir/grazoprevir does not worsen renal function in patients with hepatitis C virus infection and pre‐existing renal disease

K. Reddy, D. Roth, A. Bruchfeld, 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

The Immune Reactivity Role of HCV-Induced Liver Infiltrating Lymphocytes in Hepatocellular Damage

A. Tzakis, D. Roth, Joshua Miller, 1997, Journal of Clinical Immunology.

De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients.

P. Ruiz, G. Burke, D. Roth, 1995, Transplantation.

Prospective longitudinal assessment of hepatitis C virus infection after renal transplantation.

G. Burke, D. Roth, V. Esquenazi, 1995, Transplantation proceedings.

DEPLETION OF HEPATITIS C VIRUS FROM PROCURED KIDNEYS USING PULSATILE PERFUSION PRESERVATION1,2

G. Burke, D. Roth, Joshua Miller, 1994, Transplantation.

Transmission of hepatitis C virus with solid organ transplantation: incidence and clinical significance.

G. Burke, D. Roth, V. Esquenazi, 1993, Transplantation proceedings.

Detection of Hepatitis C Virus Infection among Cadaver Organ Donors: Evidence for Low Transmission of Disease

E. Schiff, G. Burke, D. Roth, 1992, Annals of Internal Medicine.

Transplantation of kidneys from hepatitis C‐positive donors into hepatitis C virus‐infected recipients followed by early initiation of direct acting antiviral therapy: a single‐center retrospective study

G. Ciancio, G. Burke, D. Roth, 2017, Transplant international : official journal of the European Society for Organ Transplantation.

Randomized Trial of Three Induction Antibodies in Kidney Transplantation: Long-Term Results

J. Gaynor, G. Ciancio, G. Burke, 2014, Transplantation.

Campath-1H Induction Therapy in African American and Hispanic First Renal Transplant Recipients: 3-Year Actuarial Follow-Up

J. Gaynor, G. Ciancio, G. Burke, 2008, Transplantation.

The Use of Campath-1H as Induction Therapy in Renal Transplantation: Preliminary Results

J. Gaynor, A. Tzakis, G. Ciancio, 2004, Transplantation.

Association of interleukin-10 with rejection-sparing effect in septic kidney transplant recipients.

G. Ciancio, G. Burke, D. Roth, 1996, Transplantation.

Molecular monitoring of the immunosuppressive effects of cyclosporine in renal transplant patients by using a quantitative polymerase chain reaction.

G. Burke, D. Roth, V. Esquenazi, 1993, Human immunology.

Treatment and management options for the hepatitis C virus infected kidney transplant candidate

D. Roth, M. Ladino, Adriana Dejman, 2018, Hemodialysis international. International Symposium on Home Hemodialysis.

Effect of daclizumab, tacrolimus and mycophenolate mofetil in racial minority first renal transplant recipients.

G. Ciancio, G. Burke, D. Roth, 2002, Transplantation proceedings.

Benefit of B7-1 staining and abatacept for treatment-resistant post-transplant focal segmental glomerulosclerosis in a predominantly pediatric cohort: time for a reappraisal

J. Figueiró, A. Fornoni, G. Ciancio, 2022, Pediatric Nephrology.

Laparoscopic evaluation of liver disease in chronic renal failure prior to renal transplantation.

E. Schiff, D. Roth, L. Jeffers, 1997, Gastrointestinal endoscopy.

Use of tacrolimus and mycophenolate mofetil for pancreas-kidney transplantation with or without OKT3 induction.

C. Ricordi, R. Alejandro, A. Tzakis, 1998, Transplantation proceedings.

FK 506 in simultaneous pancreas/kidney transplantation: the University of Miami experience.

A. Tzakis, G. Ciancio, G. Burke, 1997, Transplantation Proceedings.

A cluster of donor‐derived Cryptococcus neoformans infection affecting lung, liver, and kidney transplant recipients: Case report and review of literature

C. Milikowski, D. Roth, W. Kupin, 2018, Transplant infectious disease : an official journal of the Transplantation Society.

Lower tacrolimus trough levels are associated with subsequently higher acute rejection risk during the first 12 months after kidney transplantation

J. Gaynor, G. Ciancio, G. Burke, 2016, Transplant international : official journal of the European Society for Organ Transplantation.

Selection and management of hepatitis C virus-infected patients for the kidney transplant waiting list.

R. Bloom, D. Roth, 2012, Contributions to nephrology.

Kidney transplantation in the patient with hepatitis C virus infection.

J. Morales, R. Bloom, D. Roth, 2012, Contributions to nephrology.

Treatment of hepatitis C infection in patients with renal disease.

D. Roth, J. Diego, 1998, Current opinion in nephrology and hypertension.

Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation

N. Terrault, S. Feng, D. Roth, 2002, Transplantation.

Pretransplant CD4 Count Influences Immune Reconstitution and Risk of Infectious Complications in Human Immunodeficiency Virus–Infected Kidney Allograft Recipients

G. Ciancio, D. Roth, W. Kupin, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Introduction to hepatitis C virus infection in patients with kidney disease: A roadmap for nephrologists

R. Bloom, D. Roth, 2019, Seminars in dialysis.

Seminars in Dialysis

P. Byers, D. Roth, A. Asif, 2003 .

Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation.

B. Kasiske, G. Danovitch, G. Singer, 2000, Journal of the American Society of Nephrology : JASN.

Kidney transplantation outcomes in African-, Hispanic- and Caucasian-Americans with lupus

D. Roth, W. Kupin, M. Ladino, 2012, Lupus.

Randomized Trial of Mycophenolate Mofetil Versus Enteric-Coated Mycophenolate Sodium in Primary Renal Transplantation With Tacrolimus and Steroid Avoidance: Four-Year Analysis

J. Gaynor, G. Ciancio, G. Burke, 2011, Transplantation.

The Evaluation of the Renal Transplant Candidates: Clinical Practice Guidelines

B. Kasiske, D. Rush, D. Hricik, 2001 .

Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients.

M. Rudnick, B. Freedman, T. Steinman, 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients

G. Ciancio, G. Burke, D. Roth, 1998 .

EFFECTS OF IN VITRO AND IN VIVO ANTICANINE T LYMPHOCYTE AND ANTICANINE CLASS II‐SPECIFIC MONOCLONAL ANTIBODIES IN THE BEAGLE

R. Alejandro, D. Roth, Joshua Miller, 1988, Transplantation.

Lack of clinical association and effect of peripheral WBC counts on immune cell function test in kidney transplant recipients with T-cell depleting induction and steroid-sparing maintenance therapy.

T. Dohi, J. Gaynor, G. Ciancio, 2014, Transplant immunology.

The use of FK506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression.

J. Skyler, C. Ricordi, R. Alejandro, 1995, Transplantation proceedings.

IN VIVO AND IN VITRO INDUCTION OF CLASS II MOLECULES ON CANINE RENAL CELLS AND THEIR EFFECT ON THE MIXED LYMPHOCYTE KIDNEY CELL CULTURE

D. Roth, Joshua Miller, V. Pardo, 1987, Transplantation.

Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings.

A. Tsaroucha, A. Tzakis, G. Ciancio, 1997, Transplant immunology.

BK virus nephropathy after simultaneous pancreas–kidney transplantation

G. Ciancio, G. Burke, D. Roth, 2010, Clinical transplantation.

Effect of kidney transplantation on outcomes among patients with hepatitis C.

K. Reddy, J. Gaynor, G. Ciancio, 2011, Journal of the American Society of Nephrology : JASN.

A prospective study of hepatitis C virus infection in renal allograft recipients.

G. Ciancio, G. Burke, D. Roth, 1996, Transplantation.

The human bone marrow as an immunoregulatory organ.

C. Ricordi, A. Tzakis, G. Ciancio, 1999, Transplantation.

Inhibitors of mTOR and Risks of Allograft Failure and Mortality in Kidney Transplantation

S. Messinger, I. Mucsi, D. Roth, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

A renal protocol for all ages and all indications: mercapto-acetyl-triglycine (MAG3) with simultaneous injection of furosemide (MAG3-F0): a 17-year experience.

R. Leveillee, G. Sfakianakis, J. Yrizarry, 2009, Seminars in nuclear medicine.

Multivariable risk of developing new onset diabetes after transplant—results from a single‐center study of 481 adult, primary kidney transplant recipients

J. Gaynor, G. Ciancio, G. Burke, 2015, Clinical transplantation.

Risk factors for respiratory syncytial virus hospitalisation in children with heart disease

D. Roth, L. Stensballe, K Kristensen, 2009, Archives of Disease in Childhood.

Predictors of alkalosis after liver transplantation.

D. Roth, C. Cely, D. Banerjee, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

An epidemiologic study of early renal replacement therapy after orthotopic liver transplantation.

D. Roth, C. Cely, G. Contreras, 2002, Journal of the American Society of Nephrology : JASN.

Activated cytokine pattern in hepatorenal syndrome: fall in levels after successful orthotopic liver transplantation.

E. Schiff, G. Burke, D. Roth, 1993, Transplantation proceedings.

The use of daclizumab as induction therapy in combination with tacrolimus and mycophenolate mofetil in recipients with previous transplants

G. Ciancio, G. Burke, D. Roth, 2003, Clinical transplantation.

Mannose binding lectin (mbl2) haplotype frequencies in solid organ transplant patients and correlation with MBL protein levels--evaluation of complement-mediated effector pathway deficiency.

A. Tzakis, S. Pham, G. Ciancio, 2013, Transplant immunology.

Polyomavirus PCR monitoring in renal transplant recipients: detection in blood is associated with higher creatinine values.

A. Tzakis, G. Burke, D. Roth, 2001, Transplantation proceedings.

Genitourinary tuberculosis after renal transplantation: report of 3 cases and review.

C. Mies, G. Ciancio, G. Burke, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Randomized trial of rATg/Daclizumab vs. rATg/Alemtuzumab as dual induction therapy in renal transplantation: Results at 8years of follow-up.

J. Gaynor, G. Ciancio, G. Burke, 2017, Transplant immunology.

Clinical outcomes in HIV+/HCV+ coinfected kidney transplant recipients in the pre‐ and post‐direct‐acting antiviral therapy eras: 10‐Year single center experience

J. Figueiró, G. Ciancio, G. Burke, 2019, Clinical transplantation.

Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4-5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled trial.

S. Pol, D. Nelson, M. Silva, 2017, The lancet. Gastroenterology & hepatology.

A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow‐up

J. Gaynor, G. Ciancio, G. Burke, 2007, Clinical transplantation.

Erratum: Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 45 chronic kidney disease (the C-SURFER study): A combination phase 3 study. (Lancet (2015) 386 (1537-45))

D. Nelson, D. Roth, A. Bruchfeld, 2015 .

Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of Hepatitis C in patients with end stage renal disease.

E. Schiff, D. Roth, C. Levy, 2015, Journal of hepatology.

Impact of antiretroviral therapy on clinical outcomes in HIV + kidney transplant recipients: Review of 58 cases

J. Figueiró, G. Ciancio, G. Burke, 2016, F1000Research.

Treating hepatitis C viral infection in patients with chronic kidney disease: When and how

D. Roth, F. Pedraza, Marco A. Ladino Avellaneda, 2017, Clinical liver disease.

Cytomegalovirus prophylaxis with valganciclovir in kidney, pancreas–kidney, and pancreas transplantation

G. Ciancio, D. Roth, W. Kupin, 2004, Clinical transplantation.

Rejection in HLA-identical living related donor kidney transplants: lack of predictive immunologic parameters.

G. Burke, D. Roth, V. Esquenazi, 1994, Transplantation.

Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy.

A. Tsaroucha, A. Tzakis, G. Burke, 1997, Transplantation Proceedings.

Renal transplantation in a new immunosuppressive era.

G. Ciancio, G. Burke, D. Roth, 1995, Transplantation proceedings.

Use of intravenous FK506 to treat acute rejection in simultaneous pancreas-kidney transplant recipients on maintenance oral FK506.

G. Ciancio, G. Burke, D. Roth, 1997, Transplantation.

The Use of Daclizumab, Tacrolimus and Mycophenolate Mofetil in African‐American and Hispanic First Renal Transplant Recipients

G. Ciancio, G. Burke, D. Roth, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Use of intravenous tacrolimus to reverse vascular rejection in kidney and simultaneous kidney-pancreas transplantation.

P. Ruiz, G. Ciancio, G. Burke, 1998, Transplantation proceedings.

When and How Should Dialysis Patients with Anti‐Hepatitis C Antibodies be Treated?

D. Roth, J. Diego, 1997 .

A preliminary report of the safety and efficacy of fluvastatin for hypercholesterolemia in renal transplant patients receiving cyclosporine.

R. Goldberg, D. Roth, 1995, The American journal of cardiology.

Factors affecting the ten-year outcome of human renal allografts. The effect of viral infections.

G. Burke, D. Roth, V. Esquenazi, 1991, Transplantation.

Donor bone marrow, chimerism, histocompatibility and renal allograft rejection.

A. Tzakis, G. Ciancio, G. Burke, 1999, Transplantation proceedings.

Addition of anti‐CD25 to thymoglobulin for induction therapy: delayed return of peripheral blood CD25‐positive population

J. Gaynor, G. Ciancio, D. Roth, 2011, Clinical transplantation.

Hypercoagulable state associated with kidney–pancreas transplantation. Thromboelastogram‐directed anti‐coagulation and implications for future therapy

J. Figueiró, G. Ciancio, G. Burke, 2004, Clinical transplantation.

Rapidly progressive focal segmental glomerulosclerosis occurring in a living related kidney transplant donor: case report and review of 21 cases of kidney transplants for primary FSGS.

P. Ruiz, G. Burke, D. Roth, 1993, Transplantation proceedings.

Ten-year survival after simultaneous pancreas/kidney transplantation with bladder drainage and tacrolimus-based immunosuppression.

G. Ciancio, G. Burke, D. Roth, 2001, Transplantation proceedings.

Randomized Trial of Dual Antibody Induction Therapy With Steroid Avoidance in Renal Transplantation

J. Gaynor, G. Ciancio, G. Burke, 2011, Transplantation.

When is it safe to perform abdominal transplantation in patients with prior SARS‐CoV‐2 infection: A case series

J. Figueiró, G. Ciancio, G. Burke, 2021, Clinical transplantation.

Destructive allograft fungal arteritis following simultaneous pancreas-kidney transplantation.

P. Ruiz, E. Ginzburg, G. Ciancio, 1996, Transplantation.

Use of FK 506 in simultaneous pancreas/kidney transplantation: lack of impairment of glycemic or lipid metabolism.

J. Skyler, C. Ricordi, R. Alejandro, 1995, Transplantation Proceedings.

Pilot Randomized Trial of Tacrolimus/Everolimus vs Tacrolimus/Enteric-Coated Mycophenolate Sodium in Adult, Primary Kidney Transplant Recipients at a Single Center.

P. Ruiz, J. Gaynor, D. Roth, 2016, Transplantation proceedings.

Recurrent idiopathic membranous nephropathy in the renal allograft: successful treatment with the anti-CD20 monoclonal antibody rituximab

D. Roth, M. Ladino, 2009, NDT plus.

De novo ANCA-associated vasculitis occurring 14 years after kidney transplantation.

D. Roth, A. Asif, C. Toral, 2000, American Journal of Kidney Diseases.

Randomized trial of immunosuppressive regimens in renal transplantation.

J. Gaynor, G. Ciancio, G. Burke, 2011, Journal of the American Society of Nephrology : JASN.

Randomized trial of 3 maintenance regimens (TAC/SRL vs. TAC/MMF vs. CSA/SRL) with low‐dose corticosteroids in primary kidney transplantation: 18‐year results

J. Gaynor, G. Ciancio, G. Burke, 2020, Clinical transplantation.

Allograft pancreatic duct dilatation following bladder drained simultaneous pancreas-kidney transplantation: clinical significance.

B. Montalvo, G. Ciancio, G. Burke, 2000, JOP : Journal of the pancreas.

Recurrence of lupus nephritis in a renal allograft with histologic transformation of the lesion.

G. Burke, D. Roth, M. Milgrom, 1990, Transplantation.

Randomized trial of thymoglobulin versus alemtuzumab (with lower dose maintenance immunosuppression) versus daclizumab in living donor renal transplantation.

J. Gaynor, G. Ciancio, G. Burke, 2010, Transplantation proceedings.

Long-term results of kidney transplantation at the University of Miami.

G. Burke, D. Roth, A. Rosen, 1989, Clinical transplants.

REFLUX PANCREATITIS AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION TREATED BY α1 BLOCKER

G. Ciancio, G. Burke, D. Roth, 1995 .

Barriers to successful care for chronic kidney disease

Oliver Lenz, Alessia Fornoni, A. Fornoni, 2005, BMC nephrology.

Disparities Among Blacks, Hispanics, and Whites in Time From Starting Dialysis to Kidney Transplant Waitlisting

J. Gaynor, G. Ciancio, G. Burke, 2013, Transplantation.

Hemolytic uremic syndrome after multivisceral transplantation treated with intravenous immunoglobulin.

D. Roth, W. Kupin, D. Banerjee, 2003, Journal of nephrology.

Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients.

G. Ciancio, G. Burke, D. Roth, 1999, Transplantation.

Detection of antibody to hepatitis C virus in renal transplant recipients.

G. Burke, D. Roth, Joshua Miller, 1991, Transplantation.

Clinical Outcomes in Kidney Transplant Recipients Receiving Long‐Term Therapy With Inhibitors of the Mammalian Target of Rapamycin

C. Kovesdy, I. Mucsi, D. Roth, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Graft Failure Due to Noncompliance Among 628 Kidney Transplant Recipients With Long-term Follow-up: A Single-Center Observational Study

J. Gaynor, G. Ciancio, G. Burke, 2014, Transplantation.

POSTTRANSPLANT HYPERGLYCEMIA: Increased Incidence in Cyclosporine‐Treated Renal Allograft Recipients“

G. Burke, D. Roth, Joshua Miller, 1989, Transplantation.

Corticosteroid and calcineurin inhibitor sparing regimens in kidney transplantation.

D. Roth, T. Isakova, F. Cortazar, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Tacrolimus

G. Ciancio, G. Burke, D. Roth, 1997, Reactions weekly.

Donor bone marrow infusion in simultaneous pancreas/kidney transplantation with OKT3 induction: evidence for augmentation of chimerism.

J. Skyler, C. Ricordi, R. Alejandro, 1997, Transplantation proceedings.

Evidence for microchimerism in peripheral blood, bone marrow, and skin following donor bone marrow/kidney-pancreas transplantation at 3 years.

C. Ricordi, R. Alejandro, A. Tzakis, 1998, Transplantation proceedings.

Higher percentage of donor CD 34+ expression in peripheral blood of simultaneous pancreas/kidney/donor bone marrow versus than kidney/islet cell/donor bone marrow recipients.

C. Ricordi, R. Alejandro, A. Tzakis, 1998, Transplantation proceedings.

The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60.

G. Ciancio, G. Burke, D. Roth, 1997, Clinical transplantation.

Graft Failure Due to Nonadherence among 150 Prospectively-Followed Kidney Transplant Recipients at 18 Years Post-transplant: Our Results and Review of the Literature

J. Gaynor, G. Ciancio, G. Burke, 2022, Journal of clinical medicine.

Treating hepatitis C virus in dialysis patients: How, when, and why?

D. Roth, M. Ladino, J. Pagán, 2018, Seminars in dialysis.

Kidney Transplantation From a Hepatitis C Virus–Infected Donor Into an Uninfected Recipient: Ready for Prime Time?

D. Roth, M. Ladino, J. Pagán, 2020, Kidney international reports.

Should My Patient Accept a Kidney from a Hepatitis C Virus-Infected Donor?

D. Roth, M. Ladino, J. Pagán, 2020, Kidney360.

End-Stage Renal Disease and Treatment of Hepatitis C Virus Infection

D. Roth, M. Ladino, J. Pagán, 2018, Current Hepatology Reports.

Chronic kidney disease after orthotopic liver transplantation in recipients receiving tacrolimus.

J. Moon, A. Tzakis, D. Roth, 2011, Clinical nephrology.

Impact of grazoprevir and elbasvir in the treatment of hepatitis C virus–infected patients with chronic kidney disease and end‐stage renal disease

D. Roth, F. Pedraza, M. Ladino, 2016, Clinical liver disease.

Retransplantation in a patient with type 2 Jeune's syndrome.

G. Burke, D. Roth, D. Banerjee, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy.

C. Ricordi, A. Tzakis, G. Ciancio, 1996, Transplantation proceedings.

Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression.

A. Miller, A. Pinna, G. Ciancio, 2001, Transplantation proceedings.

The effects of tissue-associated and MHC class II antigen presentation on in vitro lymphoproliferative responses against canine liver and kidney cell subpopulations.

R. Leif, G. Burke, D. Roth, 1991, Transplantation.

Toward the definition of nominal tissue-associated kidney tubular cell-surface epitope(s) which cause autologous and allogeneic T cell immune reactivity.

G. Burke, D. Roth, V. Esquenazi, 1989, Transplantation Proceedings.

Transplantation of Kidneys from HCV-Positive Donors: How to Best Use a Scarce Resource.

D. Roth, M. Ladino, 2017, Journal of the American Society of Nephrology : JASN.

A Pilot Single-Blinded, Randomized, Controlled Trial Comparing BNT162b2 vs. JNJ-78436735 Vaccine as the Third Dose After Two Doses of BNT162b2 Vaccine in Solid Organ Transplant Recipients

G. Ciancio, D. Roth, W. Kupin, 2023, Transplant International.

LP02 : C-surfer: grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and chronic kidney disease

T. Hassanein, S. Pol, D. Nelson, 2015 .

Efficacy and safety of daclizumab induction for primary kidney transplant recipients in combination with tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression.

G. Ciancio, G. Burke, D. Roth, 2003, Transplantation proceedings.

A brief course of cyclosporine A pretransplant reduces posttransplant cyclosporine A requirements in beagles and humans.

G. Burke, D. Roth, V. Esquenazi, 1988, Transplantation proceedings.

The podocyte: glomerular sentinel at the crossroads of innate and adaptive immunity

A. Fornoni, G. Ciancio, D. Roth, 2023, Frontiers in immunology.

Hepatitis C Virus Infection in ESKD Patients.

D. Roth, M. Ladino, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Clinical trials: Treatment of HCV-infected patients with advanced kidney disease

D. Roth, M. Ladino, 2018, Nature Reviews Nephrology.

Single-centre study of 628 adult, primary kidney transplant recipients showing no unfavourable effect of new-onset diabetes after transplant

J. Gaynor, G. Ciancio, D. Roth, 2015, Diabetologia.

Kidney transplantation at the University of Miami.

C. Ricordi, G. Ciancio, G. Burke, 1999, Clinical transplants.

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

E. Salido, M. Sarwal, M. Rastaldi, 2011, Nature Medicine.

Recurrence of lupus nephritis after kidney transplantation.

L. Tamariz, D. Roth, W. Kupin, 2010, Journal of the American Society of Nephrology : JASN.

S. Pol, D. Nelson, M. Silva, 2017, The lancet. Gastroenterology & hepatology.

Excessive immunosuppression as a potential cause of poor survival in simultaneous liver/kidney transplantation for hepatitis C

T. Hibi, S. Nishida, D. Levi, 2014, Transplant international : official journal of the European Society for Organ Transplantation.

Randomized Trial of Mycophenolate Mofetil Versus Enteric-Coated Mycophenolate Sodium in Primary Renal Transplant Recipients Given Tacrolimus and Daclizumab/Thymoglobulin: One Year Follow-Up

J. Gaynor, G. Ciancio, G. Burke, 2008, Transplantation.

Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of Hepatitis C in patients with end stage renal disease.

E. Schiff, D. Roth, C. Levy, 2015, Journal of hepatology.

BK virus nephropathy after simultaneous pancreas–kidney transplantation

G. Ciancio, G. Burke, D. Roth, 2010, Clinical Transplantation.

Effect of kidney transplantation on outcomes among patients with hepatitis C.

K. Reddy, J. Gaynor, G. Ciancio, 2011, Journal of the American Society of Nephrology : JASN.

In Reply to 'Response to the KDOQI US Commentary on the 2018 KDIGO Hepatitis C Guideline'.

P. Reese, R. Bloom, D. Roth, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Roux‐en‐Y gastric bypass is an effective bridge to kidney transplantation: Results from a single center

J. Gaynor, G. Ciancio, G. Burke, 2018, Clinical transplantation.

Renal Function Decline is Frequent in Patients Undergoing Hepatitis C Treatment Post Kidney Transplant

D. Roth, C. Levy, Paul L. Martin, 2016 .